ePrivacy and GPDR Cookie Consent by TermsFeed Generator

LAMOTRIGIN AUROBINDO

50MG TBL NOB 10

SÚKL code 0226137
Name of the product LAMOTRIGIN AUROBINDO
_MA_MEDICATION_DETAIL_INFO_MED_NAME i LAMOTRIGIN AUROBINDO
Supplement 50MG TBL NOB 10
Strenght 50MG
Pharmaceutical form Tablet
Package 10
Route Oral use
Language of the pack Czech
Wrap type Blister
Legal status na lékařský předpis
Active substance LAMOTRIGINE (LAMOTRIGINUM)
ATC group N03AX09
ATC group name LAMOTRIGIN

Marketing authorisation information

Registration Number 21/ 656/10-C
Type of MA A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state
MA status B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till)
Placed on the market till 31. 08. 2018
MA Holder Aurovitas Pharma Polska Sp. z o.o., Warszawa
MA Holder country POLSKO
Actual MA holder Aurovitas, spol. s r.o., Praha
Actual MA holder country ČESKÁ REPUBLIKA

Back to list